The effectiveness of Alpha S1-Casein Tryptic Hydrolysate has been the subject of 7 rigorous clinical studies, conducted between 1999 and 2011 on 394 adult volunteers, all supervised by healthcare professionals. These studies were carried out according to the Clinical Best Practice Directive under the supervision of official ethics committees, and used biological means to confirm the positive impact of Alpha S1-Casein Tryptic Hydrolysateon the body (e.g. blood pressure and heart rate).

Translate »